MedPath

成都克莱蒙医药科技有限公司

Ownership
-
Established
2013-06-14
Employees
-
Market Cap
-
Website
www.cdclimb.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Levofloxacin and Sodium Chloride Injection

Product Name
左氧氟沙星氯化钠注射液
Approval Number
国药准字H20254333
Approval Date
May 27, 2025
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
左氧氟沙星氯化钠注射液
Approval Number
国药准字H20254334
Approval Date
May 27, 2025
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
左氧氟沙星氯化钠注射液
Approval Number
国药准字H20254335
Approval Date
May 27, 2025
NMPA

Iomeprol Injection

Product Name
碘美普尔注射液
Approval Number
国药准字H20244844
Approval Date
Sep 10, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.